High-purity building blocks compliant with Japanese Pharmacopoeia (JP) and cGMP standards for biopharmaceutical innovation.
The Tokyo metropolitan region—spanning major biotechnology clusters in Nihonbashi, Greater Tokyo's Kanagawa Science Park, and Tsukuba Science City—stands as one of the world's most sophisticated hubs for life sciences, peptide therapeutics, and advanced nutra-cosmeceuticals. As Japan accelerates its strategic investments in targeted biopharmaceuticals, metabolic disorder treatments, and longevity medicine, the demand for ultra-pure amino acids, protected amino acid derivatives, and customized peptide active pharmaceutical ingredients (APIs) has experienced exponential growth.
Gentolex operates as a premier global exporter and technical supply partner tailored to the stringent quality standards of the Japanese market. Adhering strictly to PMDA (Pharmaceuticals and Medical Devices Agency) regulatory expectations, Japanese Pharmacopoeia (JP) monographs, and cGMP standards, our amino acid series provide the precise molecular specifications required for solid-phase peptide synthesis (SPPS), therapeutic peptide manufacturing, and clinical-grade biochemical formulations.
Tokyo's biopharmaceutical market is unique in its demand for rigorous purity profiles, low endotoxin levels, and robust supply chain traceability. Key market vectors driving the current demand include:
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Our overall factory construction area spans 250,000 square meters under international standards to offer flexible, scalable, and cost-effective solutions for clients across Tokyo and global biopharmaceutical hubs.
Learn More About Our Capabilities
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Tailored synthesis of complex non-natural amino acids, modified side-chains, and custom peptide sequences engineered to precise client specifications.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
The manufacturing landscape for amino acids and peptide APIs is undergoing a transformation toward greener, more efficient, and hyper-precise chemical pathways. To support Tokyo's progressive R&D mandates, Gentolex implements advanced production methodologies:
Replacing traditional hazardous chemical synthesis with engineered biocatalysts. Biocatalytic pathways yield exceptionally high optical purity (>99.8% ee) while dramatically reducing carbon footprints and solvent waste.
Development of novel Fmoc/Boc orthogonal protection strategies that prevent unwanted side-reactions during complex multi-step peptide elongation, such as aggregation during long-chain GLP-1 analogue assembly.
Transitioning batch processes into continuous micro-reactor systems, enabling real-time inline PAT (Process Analytical Technology) monitoring for consistent batch-to-batch reproducibility.
Operating in Japan's highly regulated market requires more than just high purity; it demands end-to-end supply chain reliability, comprehensive documentation, and flexible logistics. Gentolex bridges global chemical production with local Japanese operational requirements through:
Explore our active pharmaceutical ingredients, custom protected amino acids, and high-purity research compounds.
Stay updated with our latest technical breakthroughs, biopharmaceutical manufacturing developments, and global supply chain updates.
Introduction to Selank Acetate API Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Developed for neuropharmacological applications...
Read More
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier. We provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and life science labs worldwide...
Read More
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and inflammatory regulation...
Read More
With continuous developments in neuroscience and life science research, neuroactive peptides have become a crucial research focus. Semax, a synthetic peptide derived from an ACTH fragment, features unique molecular properties...
Read More
SS-31 API, also known as Elamipretide or MTP-131, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics and functional stability...
Read MoreTechnical insights regarding quality standards, shipping to Tokyo, regulatory compliance, and custom synthesis options.